Association of HLA-C*06:02 Status With Differential Response to Ustekinumab in Patients With Psoriasis: A Systematic Review and Meta-analysis

IMPORTANCE: Previous research showed a differential response to ustekinumab therapy based on HLA-C*06:02 status in patients with psoriasis but consisted mostly of small (and sometimes inconclusive) cohort studies. OBJECTIVE: To assess whether HLA-C*06:02 status is associated with a differential resp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Dermatol
Glavni autori: van Vugt, Lieke J., van den Reek, Juul M. P. A., Hannink, Gerjon, Coenen, Marieke J. H., de Jong, Elke M. G. J.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563550/
https://ncbi.nlm.nih.gov/pubmed/30994858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.0098
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items